Formycon AG
FYB
ISIN DE000A1EWVY8 / Valor 12194189
Formycon AG
UMushroom community rating:
About company
Formycon AG is a prominent independent developer specializing in biosimilars, which are biologic drugs designed to be highly similar to already approved biopharmaceutical medicines. The company focuses on creating treatments primarily in the fields of ophthalmology and immunology, as well as addressing other significant chronic diseases. Formycon's operations encompass the entire development process, from technical and pharmaceutical development to conducting clinical trials, and preparing and submitting regulatory approval dossiers. By developing biosimilars, Formycon aims to enhance patient access to essential medications, ensuring that these follow-on products maintain the same quality, efficacy, and safety as their reference counterparts.
Summarized from source with an LLMView SourceSector: HealthcareKey figures
Performance
Volatility
476 M
Market cap (USD)
18,952
Daily traded volume (Shares)
53.2 / 51
1 day high/low (USD)
52 weeks high/low (USD)
Dividend ex-date
Dividend (USD)
Dividend yield (p.a.)
Est dividend (USD)
Est dividend yield
P/E ratio
Est P/E ratio
EPS (USD)
Est EPS (USD)
Ratings & reviews
EQUITIES OF THE SAME SECTOR
